What Researchers Did
Researchers injected a patient's own fat-derived stem and regenerative cells around the edges of long-lasting leg ulcers in people with poor blood flow to the legs.
What They Found
In a small clinical trial of 20 patients with peripheral arterial disease and chronic leg ulcers, of whom 10 were treated with autologous adipose-derived regenerative cells (ADRCs), every treated patient had a smaller and shallower ulcer, and six of the 10 had complete healing. Patients were followed at 4, 10, 20, 60 and 90 days. Treated patients also had less ulcer-related pain. The abstract reports no adverse events linked to the technique. Cell testing showed the injected product contained adipose-derived stem cells, and the authors state that ulcer closure was due to the cells and not to growth factors in the extract.
What This Means for Canadian Patients
The abstract does not address hyperbaric oxygen therapy or describe its use in this study, so it offers no information on HBOT for leg ulcers. It covers a cell-based procedure in a small group of people with poor leg circulation and chronic ulcers. Anyone with a leg ulcer should discuss treatment options with their own care team.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
Only 10 patients were treated, the abstract does not report a statistical comparison with the untreated patients, and it describes results up to 90 days, so the findings are preliminary.